Applied Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Applied Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2024.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $9.21M, a 466% increase year-over-year.
  • Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $15.6M, a 112% increase year-over-year.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $15.6M, a 112% increase from 2023.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.36M, a 23.4% decline from 2022.
  • Applied Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.6M, a 14.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $15.6M +$8.21M +112% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $7.36M -$2.24M -23.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $9.6M -$1.57M -14.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $11.2M +$3.15M +39.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $8.03M +$1.86M +30.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $6.17M +$5.9M +2169% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 $272K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.